PLoS Pathogens (Mar 2022)

Engineering selectivity of Cutibacterium acnes phages by epigenetic imprinting.

  • Nastassia Knödlseder,
  • Guillermo Nevot,
  • Maria-José Fábrega,
  • Julia Mir-Pedrol,
  • Marta Sanvicente-García,
  • Nil Campamà-Sanz,
  • Bernhard Paetzold,
  • Rolf Lood,
  • Marc Güell

DOI
https://doi.org/10.1371/journal.ppat.1010420
Journal volume & issue
Vol. 18, no. 3
p. e1010420

Abstract

Read online

Cutibacterium acnes (C. acnes) is a gram-positive bacterium and a member of the human skin microbiome. Despite being the most abundant skin commensal, certain members have been associated with common inflammatory disorders such as acne vulgaris. The availability of the complete genome sequences from various C. acnes clades have enabled the identification of putative methyltransferases, some of them potentially belonging to restriction-modification (R-M) systems which protect the host of invading DNA. However, little is known on whether these systems are functional in the different C. acnes strains. To investigate the activity of these putative R-M and their relevance in host protective mechanisms, we analyzed the methylome of six representative C. acnes strains by Oxford Nanopore Technologies (ONT) sequencing. We detected the presence of a 6-methyladenine modification at a defined DNA consensus sequence in strain KPA171202 and recombinant expression of this R-M system confirmed its methylation activity. Additionally, a R-M knockout mutant verified the loss of methylation properties of the strain. We studied the potential of one C. acnes bacteriophage (PAD20) in killing various C. acnes strains and linked an increase in its specificity to phage DNA methylation acquired upon infection of a methylation competent strain. We demonstrate a therapeutic application of this mechanism where phages propagated in R-M deficient strains selectively kill R-M deficient acne-prone clades while probiotic ones remain resistant to phage infection.